This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biomarin Pharmaceutical Inc (BMRN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 568.78M 180.53M 46.27M 88.08M
Receivables 117.82M 109.07M 110.93M 93.88M
Inventories 162.60M 128.70M 130.12M 109.70M
Other Current Assets 41.71M 25.51M 4.99M 1.46M
Total Current Assets 1.14B 743.46M 469.80M 504.26M
Property, Plant & Equipment, Gross 504.36M 433.60M 384.72M 306.94M
Accumulated Depreciation & Depletion 185.04M 149.12M 115.74M 85.08M
Property, Plant & Equipment, Net 319.32M 284.47M 268.97M 221.87M
Intangibles 163.15M 162.98M 180.28M 103.65M
Other Non-Current Assets 424.69M 133.68M 110.44M 143.47M
Total Non-Current Assets 1.11B 858.18M 833.88M 758.36M
Liabilities & Shareholder Equity
Total Assets 2.25B 1.60B 1.30B 1.26B
Accounts Payable 48.78M 23.99M 12.24M 13.75M
Short Term Debt 0.00 23.36M 0.00 0.00
Other Current Liabilities 3.60M 2.07M 4.07M 6.54M
Total Current Liabilities 183.27M 170.43M 94.12M 83.84M
Long Term Debt 655.57M 324.86M 348.33M 377.52M
Deferred Income Taxes 0.00 33.30M 35.13M 36.52M
Other Non-Current Liabilities 69.34M 57.29M 53.05M 47.48M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 724.90M 415.45M 436.51M 461.52M
Total Liabilities 908.18M 585.88M 530.63M 545.37M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.34B 1.02B 773.05M 717.26M
Common Par 144.00K 126.00K 115.00K 111.00K
Additional Paid In Capital 2.06B 1.56B 1.20B 1.09B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -715.80M -539.45M -425.10M -371.26M
Treasury Stock -7.42M -6.60M -3.94M -1.96M
Other Equity Adjustments 5.02M -202.00K 4.89M 188.00K
Total Capitalization 2.00B 1.34B 1.12B 1.09B
Total Equity 1.34B 1.02B 773.05M 717.26M
Total Liabilities & Stock Equity 2.25B 1.60B 1.30B 1.26B
Total Common Shares Outstanding 143.46M 125.81M 114.79M 110.63M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 137.76M 120.27M 112.12M 103.09M
Diluted Weighted Shares Outstanding 137.76M 120.27M 112.12M 125.67M
Number of Employees 1341 1089 1002 871
Number of Part-Time Employees 0 0 0 0
BMRN News

BMRN Biomarin Pharmaceutical Inc

Analysts Ratings for BMRN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 10 10 10 9
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BMRN ANALYST REPORT

Brokerage Partners

BMRN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs